Alkermes Highlights Signs and Symptoms of Schizophrenia

Jan 31, 2022 12:00 PM ET

Schizophrenia is a complex brain disorder that can significantly impact patients. Fortunately, there are treatment options that may help.

Learn more about the signs, symptoms, and treatments from National Institute of Mental Health (NIMH).

About Alkermes
Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on addiction, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at